Caprock Group’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$188K Sell
39,880
-2,604
-6% -$12.9K ﹤0.01% 1177
2026
Q1
$200K Buy
42,484
+8,925
+27% +$46.5K ﹤0.01% 1053
2025
Q4
$171K Sell
33,559
-852
-2% -$4.43K ﹤0.01% 1131
2025
Q3
$155K Buy
+34,411
New +$152K ﹤0.01% 1083
2025
Q1
$129K Buy
21,149
+412
+2% +$2.08K ﹤0.01% 1032
2024
Q4
$83.6K Buy
+20,737
New +$92.9K ﹤0.01% 971
2024
Q3
Sell
-20,864
Closed -$93.1K 950
2024
Q2
$93.1K Buy
20,864
+115
+0.6% +$551 ﹤0.01% 829
2024
Q1
$97.5K Buy
20,749
+6,984
+51% +$26.7K 0.01% 699
2023
Q4
$67.7K Buy
+13,765
New +$67.4K ﹤0.01% 682
2023
Q3
Sell
-14,275
Closed -$136K 678
2023
Q2
$136K Buy
+14,275
New +$121K 0.01% 632

Other funds holding MPT

Caprock Group's MPT Position: Q2 2026 in Review

Caprock Group reduced its Medical Properties Trust (MPT) stake by 6.1% in Q2 2026, selling an estimated $12.9K and leaving 39,880 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

Caprock Group first reported a position in MPT in Q2 2023 and has held it in 10 quarters since. The position peaked at $200K in Q1 2026. 488 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Caprock Group held 39,880 shares of Medical Properties Trust worth $188K as of Q2 2026.
  • Caprock Group sold 2,604 Medical Properties Trust shares in Q2 2026, an estimated $12.9K.
  • Medical Properties Trust made up ﹤0.01% of Caprock Group's portfolio in Q2 2026, its #1177 holding.
  • Caprock Group first reported a position in Medical Properties Trust in Q2 2023 and has held it in 10 quarters since.
  • Caprock Group's Medical Properties Trust position peaked at $200K in Q1 2026.
  • 488 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.